New preventive care for cardiac disease patients
The CleverHealth Network ecosystem coordinated by Helsinki University Hospital (HUS) is soon launching a remarkable project focusing on cardiac disease. The Clever-P project develops new, preventive care to mitigate secondary cardiac events in patients. In the project, HUS is developing digital care paths to provide more personalised care for cardiac patients. The partners collaborating in this project are HUS and biotechnology company Amgen.
In the picture from left: Juha Tuominen, Chief Executive Officer of HUS, Antti Vento, Director of HUS Heart and Lung Center and Niilo Färkkilä, Amgen Country Manager for Finland and the Baltics.
The project aims to offer better and even more efficient care to thousands of cardiac disease patients within the HUS primary healthcare. Many of these patients may be at risk for new cardiovascular events, posing a considerable strain to the healthcare system. To personalise intensive support and impactful care for the patients, the information obtained through the HUS data lake will be used as a tool to develop preventive care.
Targeting at identifying high-risk patients
The project partners first aim to identify the patients with the highest risk, who, based on their genetic risk, have a higher probability for secondary cardiac events. They form 5-10 % of all the cardiac patients in primary care, and for them, an intensive care and support will be personalised to prevent secondary cardiac events. The patients with normal risk, amounting to 90 % of cardiac disease patients, will be directed to a research which compares the impact and feasibility of traditional care and digitally supported, renewed care path.
The renewed digital care path brings remarkable benefits to patients
In the Clever-P project, the partners of the collaborative network define together the actual tools and processes that will support the cultivation of information based on health data in predicting and preventing cardiac disease, and to build foundations for the use of genome data. The project also aims to demonstrate the benefits of customer-centric digital care paths in comparison with traditional care paths. In the digital care path, the care personnel and patients will be able to use the Health Village application, which has been developed in HUS earlier.
Personalised care forms the foundation for value-based health care. Director Antti Vento from HUS Heart and Lung Center estimates that the patient care will become more efficient and cost-effective, if the secondary prevention of cardiac disease patients is targeted correctly. For the patients this would mean that the more personalised and effective processes and tools ensure a faster access to care and, in particular, secondary cardiac events can be prevented.
”HUS has a clear strategy to become the best player in Europe in patient-centered digitalisation of public healthcare. We believe that the partners in this collaborative project have what it takes to develop personalised, world-class solutions with top-level quality assurance and data security,” says Juha Tuominen, the Chief Executive Officer of HUS.
Top talents of their own fields working together for the benefit of patients
The project, which runs within the CleverHealth Network, engages HUS and Amgen Europe, which both contribute to the project with millions of euros, and bring strong expertise and information for the implementation of the project. The multi-disciplinary project brings together HUS’s medical expertise and patient data from their data lakes and technology expertise from Amgen.
The pharmaceutical company Amgen brings their top expertise on bio technologies to the project. Niilo Färkkilä, Country Manager for Finland and the Baltics comments: ”We are excited to develop a partnership with an innovative actor such as HUS. Together we can develop the care process to better identify patients with a higher risk for secondary cardiac events, and to treat them more efficiently. this project with where the best practices of healthcare systems are brought together. Together, we can improve the impact of the care and design better approaches to reduce the risk of recurrent events.”
The Project Director of CleverHealth Network Mirka Tammi concludes: ”The joint Clever-P project is an example of a project for which the CleverHealth Network ecosystem funded by Business Finland exists. The projects provide us with concrete new tools to solve a number of challenges in healthcare, and we will be able to help as many patients as possible.”
More information:
Juha Sinisalo, Head of Department, HUS Heart and Lung Center
Tel. 050 427 9007, e-mail: juha.sinisalo(at)hus.fi
Timo Seppälä, Government Affairs Senior Manager, Amgen AB subsidiary in Finland,
Tel. +358 40 5180328, e-mail: timo.seppala(at)amgen.com
CleverHealth Network is health technology ecosystem coordinated by HUS in which companies and health care experts together develop better treatment solutions. Product and service innovations are based on HUS’s extensive health data and the leading expertise of clinicians. The participants of the ecosystem, funded by Business Finland, include BCB Medical, BC Platforms, CGI, Elisa, Fujitsu, GE, Innofactor, Microsoft, Pfizer, Planmeca, Productivity Leap, Roche, Takeda, Tieto and Varian.
- 15.08.2024 12:50
Medtronic joins CleverHealth Network ecosystem - 19.06.2024 13:49
CleverHealth Network collaboration between HUS and Fujitsu moves dialysis from hospitals to homes - 06.05.2024 14:27
eMOM project has been completed with promising findings in helping mothers to manage their gestational diabetes - 06.05.2024 13:56
The PHEMS EU project promotes the use of pediatric healthcare data between hospitals - 31.01.2024 11:44
ONCOVALUE project to automate data collection and analytics in assessing real-life effectiveness of cancer care - 26.01.2024 13:33
Impressive results, new ideas and interaction at the CleverHealth Network annual seminar - 02.11.2023 12:35
New remote care solution improves patients' quality of life and brings significant savings to society - 22.09.2023 10:26
A graduate thesis within CleverHealth Network studied the cost-effectiveness of clinical support system for diagnosing vasculitis - 22.08.2023 15:06
Acute leukemia project shows great results in optimizing oncology diagnostic and treatment automation - 22.05.2023 09:24
AstraZeneca joins the CleverHealth Network ecosystem - 03.05.2023 14:47
Tackling pandemics event brings latest results from virus diagnostics to creating health safe spaces - 27.04.2023 09:25
Hewlett Packard Enterprise joins CleverHealth Network - 30.01.2023 10:54
CleverHealth Network ecosystem of digital health innovations yields significant results - 07.12.2022 12:23
Significant EU funding for implementing value-based cancer care at European cancer hospitals - 07.10.2022 09:20
Finnish opera singers contribute to E3 project in detecting differences between people as emitters of aerosols - 10.06.2022 14:28
CleverHealth Network ecosystem and E3 Excellence in Pandemics Response project showcased at HIMSS22 Europe - 18.05.2022 14:25
HUS Acamedic is a certified and scalable virtual research and analytics environment for secure processing of health data - 14.03.2022 09:00
CleverHealth Network showcased at HIMSS Global Health Conference 2022 in March - 17.02.2022 07:37
Novartis is the new partner in the CleverHealth Network ecosystem - 10.12.2021 13:11
Finland must renew its forerunner position in healthcare interoperability - 25.11.2021 14:09
The pandemic boosted the multidisciplinary E3 project on indoor health safety - 11.11.2021 09:51
Telia joins the CleverHealth Network ecosystem - 28.10.2021 10:29
Siemens Healthineers joins the CleverHealth Network collaboration - 04.10.2021 10:43
Fujitsu Finland co-develops a digital service to support treatment of gestational diabetes - 27.05.2021 16:27
Health technology research seeks for tools to support the daily life of dialysis patients and their care personnel - 04.05.2021 17:54
Close collaboration around algorithms in the AI Head Analysis project - 27.04.2021 16:07
Planmeca brings their expertise to CleverHealth Network's AI Head Analysis project focusing on early detection of cerebral hemorrhages - 06.04.2021 10:00
Roche the newest partner of CleverHealth Network - 26.03.2021 16:14
Mobile application to treat gestational diabetes - 01.02.2021 10:30
New preventive care for cardiac disease patients - 21.12.2020 15:00
News on novel initiatives and progress of ecosystem projects were shared at the CleverHealth Network event - 01.12.2020 15:01
Kimmo Porkka's project team harnesses the latest technologies to implement personalised therapies - 05.11.2020 15:30
Smart applications for home dialysis help the daily life of dialysis patients and medical staff - 15.06.2020 15:17
CleverHealth Network ecosystem projects are moving forward - 13.03.2020 13:00
Home dialysis for better quality of life and more efficient treatment - 05.03.2020 15:43
CleverHealth Network projects facilitate diagnostic reliability and improve patient safety - 19.02.2020 15:31
CleverHealth Network wants to start new projects – Pfizer latest partner to join the ecosystem - 27.01.2020 13:00
Fresh media coverage of CleverHealth Network - 24.01.2020 10:49
Networking event in December 2019 was a success - 29.11.2019 13:00
Finnish ecosystem of health innovations continues to grow - 29.08.2019 13:00
CleverHealth Network participated, for the first time, in the HIMSS & Health 2.0 conference organized in Messukeskus, Helsinki 11–13 June 2019. - 10.06.2019 15:00
Digital health innovation ecosystem CleverHealth Network granted Growth Engine status and significant additional funding - 17.04.2019 09:00
Faster and more effective care through artificial intelligence - 28.02.2019 12:45
Aiming for easy and safe remote glucose monitoring for diabetic children - 05.12.2018 15:54
HUS recognised for healthcare IT ecosystem - 01.12.2018 15:00
AI-based diagnostic tool to examine cerebral hemorrhage - 07.03.2018 13:43
AI application for treatment of gestational diabetes - 19.09.2017 17:11
Launching a new ecosystem of digital health innovations